Different Interaction Between The Agonist Jn403 And The Competitive Antagonist Methyllycaconitine With The Human Alpha 7 Nicotinic Acetylcholine Receptor

Hugo R. Arias,Ruo-Xu Gu,Dominik Feuerbach,Dong-Qing Wei

DOI: https://doi.org/10.1021/bi901999v

IF: 3.321

2010-01-01

Biochemistry

Abstract:The interaction of the agonist JN403 with the human (h) alpha 7 nicotinic acetylcholine receptor (AChR) was compared to that for the competitive antagonist methyllycaconitine (M LA). The receptor selectivity of JN403 was studied on the h alpha 7, h alpha 3 beta 4, and h alpha 4 beta 2 AChRs. The results established that the cationic center and the hydrophobic group found in JN430 and M LA are important for the interaction with the AChRs. MLA preincubation inhibits JN403-induced Ca(2+) influx in GH3-h alpha 7 cells with a potency 160-fold higher than that when MLA is co-injected with JN403. The most probable explanation, based on our dynamics results, is that MLA (more specifically the 3-methy1-2,5-dioxopyrrole ring and the B-D rings) stabilizes the resting conformational state. The order of receptor specificity for JN403 is as follows: h alpha 7 > h alpha 3 beta 4 (similar to 40-fold) > h alpha 4 beta 2 (similar to 500-fold). This specificity is based on a larger number of hydrogen bonds between the carbamate group (another pharmacophore) of JN403 and the h alpha 7 sites, the electrostatic repulsion between the positively charged residues around the h alpha 3 beta 4 sites and the cationic center of JN403, fewer hydrogen bonds for the interaction of JN403 with the h alpha 3 beta 4 AChR, and an unfavorable van der Waals interaction between JN403 and the alpha 4-beta 2 interface. The higher receptor specificity for JN403 could be important for the treatment of alpha 7-related disorders, including dementias, pain-related ailments, depression, anxiety, and wound healing.